the therapeutic outcome in patients with advanced hodgkin 's disease has improved considerably since the advent of mopp chemotherapy ( mechlorethamine , vincristine , procarbazine , and prednisone ) and mopp-like regimens .
C0042679
vincristine
C0066789
mopp